Literature DB >> 12716019

Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients.

Marie-Catherine Boll1, Mireya Alcaraz-Zubeldia, Sergio Montes, Luis Murillo-Bonilla, Camilo Rios.   

Abstract

To determine whether or not the occurrence of sporadic amyotrophic lateral sclerosis (sALS) is associated with both excess nitric oxide (NO) metabolites and decreased protective superoxide dismutase (SOD) activity in the cerebrospinal fluid (CSF), we measured nitrate concentration and SOD activity in the CSF of sALS patients and in age- and gender-matched controls. We found stable NO metabolite levels to be significantly higher and SOD activity lower in the CSF of sALS patients. In addition, SOD showed a negative correlation with motor neuron axonal damage expressed as the amplitude of motor action potentials in upper limbs. Our results provide new evidence in vivo suggesting that NO products and SOD activity play a role in oxidant/ antioxidant imbalance in sporadic ALS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716019     DOI: 10.1023/a:1022853531855

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations.

Authors:  J Jacobsson; P A Jonsson; P M Andersen; L Forsgren; S L Marklund
Journal:  Brain       Date:  2001-07       Impact factor: 13.501

2.  Preparation and assay of superoxide dismutases.

Authors:  J D Crapo; J M McCord; I Fridovich
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

4.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

5.  Superoxide dismutase assays.

Authors:  L Flohé; F Otting
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.

Authors:  L Xu; J A Enyeart; J J Enyeart
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

7.  Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis.

Authors:  D Taskiran; A Sagduyu; N Yüceyar; F Z Kutay; S Pögün
Journal:  Int J Neurosci       Date:  2000       Impact factor: 2.292

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  8 in total

Review 1.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

Review 2.  CSF markers in amyotrophic lateral sclerosis.

Authors:  Joanna Tarasiuk; Alina Kułakowska; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-04       Impact factor: 3.575

Review 3.  Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.

Authors:  Pierre-François Pradat; Michel Dib
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases.

Authors:  Marie-Catherine Boll; Mireya Alcaraz-Zubeldia; Sergio Montes; Camilo Rios
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

Review 5.  Oxidative Stress in Neurodegenerative Diseases.

Authors:  Ewa Niedzielska; Irena Smaga; Maciej Gawlik; Andrzej Moniczewski; Piotr Stankowicz; Joanna Pera; Małgorzata Filip
Journal:  Mol Neurobiol       Date:  2015-07-22       Impact factor: 5.590

Review 6.  Implications of glial nitric oxide in neurodegenerative diseases.

Authors:  Jose Enrique Yuste; Ernesto Tarragon; Carmen María Campuzano; Francisco Ros-Bernal
Journal:  Front Cell Neurosci       Date:  2015-08-17       Impact factor: 5.505

Review 7.  Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?

Authors:  Laura Robelin; Jose Luis Gonzalez De Aguilar
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

Review 8.  Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.

Authors:  Tuuli-Maria Sonninen; Gundars Goldsteins; Nihay Laham-Karam; Jari Koistinaho; Šárka Lehtonen
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.